Seeing Is Believing
Currently out of the existing stock ratings of Mayank Mamtani, 200 are a BUY (88.5%), 25 are a HOLD (11.06%), 1 are a SELL (0.44%).
Analyst Mayank Mamtani works at B. RILEY with a stock forecast success ratio of 31.63% fulfilled within 148.52 days on average. Previously, Mayank Mamtani worked at B. RILEY SECURITIES.
Mayank Mamtani’s has documented 447 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALT, Altimmune at 28-Mar-2024.
Analyst best performing recommendations are on INMB (INMUNE BIO).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 11/9/2023. The price target of $8 was fulfilled within 39 days with a profit of $5.55 (226.53%) receiving and performance score of 58.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2.5
$-0.28 (-10.07%)
1 years 2 months 13 days ago
1/1 (100%)
$1.86 (290.63%)
145
Buy
30
1 years 10 months 6 days ago
0/1 (0%)
$22.32 (290.63%)
Buy
3 years 7 months 28 days ago
0/1 (0%)
$59.52 (163.16%)
Which stock is Mayank Mamtani is most bullish on?
Which stock is Mayank Mamtani is most reserved on?
What Year was the first public recommendation made by Mayank Mamtani?